tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
SNTI
Senti Biosciences
RESEARCH TOOLSreports

Senti Biosciences (SNTI) Stock News & Sentiment

246 Followers
Senti Biosciences Plans Tax-Free Holding Company Reorganization
Premium
Company Announcements
Senti Biosciences Plans Tax-Free Holding Company Reorganization
10d ago
8K
SNTI
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
Premium
Ratings
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
15d ago
SNTI
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
Premium
Company Announcements
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
23d ago
8K
SNTI
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
Premium
Ratings
Promising Potential of SENTI-202 in Treating Acute Myeloid Leukemia: A Buy Recommendation Despite Financial Risks
4M ago
SNTI
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
Premium
Ratings
Promising Phase 1 Results and Favorable Safety Profile Drive Buy Rating for Senti Biosciences’ SENTI-202 in AML Treatment
4M ago
SNTI
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
4M ago
HD
LE
Why Is Senti Biosciences Stock (SNTI) Up Today?
Premium
Market News
Why Is Senti Biosciences Stock (SNTI) Up Today?
4M ago
SNTI
More SNTI News >

SNTI News on the Web

Senti Biosciences Plans Tax-Free Holding Company Reorganization
TipRanks News
Bearish
Buy Rating on SENTI-202 Driven by Strong Early AML Efficacy and De-Risking Regulatory Designations Despite Financing Overhang
TipRanks News
Bullish
Senti Bio reports Q4 EPS (53c), consensus (47c)
TipRanks News
Bullish
Senti Biosciences Amends Lease, Restructures GeneFab Sublease
TipRanks News
Neutral
Senti Bio (SNTI) Completes Enrollment in Phase 1 Trial for SENTI-202
GuruFocus News
Bullish
Senti Bio completes enrollment in Phase 1 trial of SENTI-202
TipRanks News
Bullish
After-Hours Rally: Stoke Therapeutics, Alpha Tau Medical, Compass Pathways Lead Biotech Movers
rttnews
Neutral
Senti Biosciences Secures FDA RMAT Designation For SENTI-202
rttnews
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNTI’s Media Buzz Sentiment?
Currently, no data Available
What is SNTI’s weekly average amount of articles?
Currently, no data Available
What is SNTI’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week